FRANKFURT Feb 29 German generic drugmaker Stada raised the prospect of a slight increase in adjusted profit this year after 2015 adjusted core earnings fell 10 percent as the low rouble weighed on the value of its sales in Russia.
Adjusted 2015 earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 10 percent to 389.4 million euros ($424 million), Stada said in a statement on Monday, citing preliminary results.
18:52 Astros avoid arbitration with Dallas Keuchel, George Springer18
13:48 Wells Fargo Profit Falls 5.4% as Mortgage Revenue Declines24
12:08 Bank of America Profit Rises 43% on Trading Gains, Cost Cuts23
12:02 Bank of America tops earnings forecast, predicts 'significant increase' in net interest income20